Iovance Biotherapeutics (IOVA) Tax Rate (2023 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Tax Rate of 0.88% for Q1 2026, down 68.0% year-over-year from 2.74% in Q1 2025, and down 99.22% quarter-over-quarter from 111.88% in Q4 2025.
Iovance Biotherapeutics (IOVA) Tax Rate (2023 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Tax Rate for 4 consecutive years, with 0.88% the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Rate fell 68.0% year-over-year to 0.88%; the TTM figure through Mar 2026 stood at 22.93% (up 2207.0% YoY), while the FY2025 annual figure was 21.0%, up 2025.0% from the prior year.
- Tax Rate retreated to 0.88% in Q1 2026 per IOVA's latest filing, from 111.88% in the prior quarter.
- Across five years, Tax Rate topped out at 111.88% in Q4 2025 and bottomed at 2.08% in Q4 2024.
- Historically, Tax Rate has averaged 10.05% across 4 years, with a median of 1.38% in 2024.
- Annual changes were most pronounced in 2024 — Tax Rate sank 360 bps — and 2025, when it surged 11396 bps.
- Iovance Biotherapeutics' Tax Rate stood at 1.52% in 2023, then sank by 236 bps to 2.08% in 2024, then jumped by 5484 bps to 111.88% in 2025, then plunged by 99 bps to 0.88% in 2026.
- Business Quant data shows IOVA's Tax Rate at 0.88% in Q1 2026, 111.88% in Q4 2025, and 2.57% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn | 2.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.88% |
| Jun 30, 2026 | 2.88% |
| Jun 30, 2026 | 2.88% |
| Mar 31, 2026 | 0.88% |
| Mar 31, 2026 | 0.88% |
| Mar 31, 2026 | 0.88% |
| Dec 31, 2025 | 111.88% |
| Dec 31, 2025 | 111.88% |
| Dec 31, 2025 | 111.88% |
| Sep 30, 2025 | 2.57% |
| Sep 30, 2025 | 2.57% |
| Sep 30, 2025 | 2.57% |
| Jun 30, 2025 | -1.82% |
| Jun 30, 2025 | -1.82% |
| Jun 30, 2025 | -1.82% |
| Mar 31, 2025 | 1.56% |
| Mar 31, 2025 | 1.56% |
| Mar 31, 2025 | 1.56% |
| Dec 31, 2024 | -2.08% |
| Dec 31, 2024 | -2.08% |